These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20671370)

  • 21. Increased heparin cofactor II levels in women taking oral contraceptives.
    Toulon P; Bardin JM; Blumenfeld N
    Thromb Haemost; 1990 Nov; 64(3):365-8. PubMed ID: 2096488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of a novel isoform of heparin cofactor II in human liver.
    Bano S; Fatima S; Ahamad S; Ansari S; Gupta D; Tabish M; Rehman SU; Jairajpuri MA
    IUBMB Life; 2020 Oct; 72(10):2180-2193. PubMed ID: 32827448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-function relationships in heparin cofactor II: spectral analysis of aromatic residues and absence of a role for sulfhydryl groups in thrombin inhibition.
    Church FC; Meade JB; Pratt CW
    Arch Biochem Biophys; 1987 Dec; 259(2):331-40. PubMed ID: 3426230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta2-glycoprotein I protects thrombin from inhibition by heparin cofactor II: potentiation of this effect in the presence of anti-beta2-glycoprotein I autoantibodies.
    Rahgozar S; Giannakopoulos B; Yan X; Wei J; Cheng Qi J; Gemmell R; Krilis SA
    Arthritis Rheum; 2008 Apr; 58(4):1146-55. PubMed ID: 18383370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin cofactor II-thrombin complex in MPS I: a biomarker of MPS disease.
    Randall DR; Sinclair GB; Colobong KE; Hetty E; Clarke LA
    Mol Genet Metab; 2006 Jul; 88(3):235-43. PubMed ID: 16497528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion mutagenesis of heparin cofactor II: defining the minimum size of a thrombin inhibiting serpin.
    Sheffield WP; Blajchman MA
    FEBS Lett; 1995 May; 365(2-3):189-92. PubMed ID: 7781777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin.
    Holland CA; Henry AT; Whinna HC; Church FC
    FEBS Lett; 2000 Nov; 484(2):87-91. PubMed ID: 11068038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.
    Langford-Smith K; Arasaradnam M; Wraith JE; Wynn R; Bigger BW
    Mol Genet Metab; 2010 Mar; 99(3):269-74. PubMed ID: 19926322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An enzyme-linked immunosorbent assay for heparin cofactor II (HCII). Application to the measurement of HCII in clinical materials.
    Toulon P; Costa JM; Amiral J
    Clin Chim Acta; 1992 Jan; 205(1-2):65-73. PubMed ID: 1521342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan.
    Tanaka KA; Szlam F; Vinten-Johansen J; Cardin AD; Levy JH
    Thromb Haemost; 2005 Oct; 94(4):808-13. PubMed ID: 16270635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombin inhibition by HCII in the presence of elastase-cleaved HCII and thrombin-HCII complex.
    Maekawa H; Sato H; Tollefsen DM
    Thromb Res; 2000 Dec; 100(5):443-51. PubMed ID: 11150588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
    Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
    Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variants and evolutionary analyses of heparin cofactor II.
    Kumar A; Bhandari A; Sarde SJ; Goswami C
    Immunobiology; 2014 Sep; 219(9):713-28. PubMed ID: 24950623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis.
    Toulon P; Vitoux JF; Fiessinger JN; Sicard D; Aiach M
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):435-9. PubMed ID: 1718466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of heparin cofactor II in injured human skin: a potential role in wound healing.
    Hoffman M; Loh KL; Bond VK; Palmieri D; Ryan JL; Church FC
    Exp Mol Pathol; 2003 Oct; 75(2):109-18. PubMed ID: 14516771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligand binding to thrombin exosite II induces dissociation of the thrombin-heparin cofactor II(L444R) complex.
    Han JH; Tollefsen DM
    Biochemistry; 1998 Mar; 37(9):3203-9. PubMed ID: 9485475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of thrombin with heparin cofactor II and antithrombin III on prostacyclin production by cultured endothelial cells.
    Kaji T; Itoh F; Hayakawa Y; Oguma Y; Sakuragawa N
    Thromb Res; 1989 Oct; 56(1):99-107. PubMed ID: 2512688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues.
    Kamp P; Strathmann A; Ragg H
    Thromb Res; 2001 Mar; 101(6):483-91. PubMed ID: 11323006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of the chemotactic activity of heparin cofactor II proteolysis products.
    Hoffman M; Pratt CW; Corbin LW; Church FC
    J Leukoc Biol; 1990 Aug; 48(2):156-62. PubMed ID: 2196322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.